Page last updated: 2024-08-23

colforsin and Abnormality, Heart

colforsin has been researched along with Abnormality, Heart in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (66.67)18.2507
2000's1 (33.33)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hatano, Y; Iranami, H; Kakutani, T; Kimoto, Y; Maeda, H; Okamoto, K1
Kozlik-Feldmann, R; Netz, H; Pilz, G; Reber, D; Reithmann, C; Welz, A; Werdan, K1
Kanai, T; Kasajima, T; Nishikawa, T1

Other Studies

3 other study(ies) available for colforsin and Abnormality, Heart

ArticleYear
Use of corfolsin dalopate following cardiac surgery in a neonate.
    Anesthesiology, 2002, Volume: 97, Issue:2

    Topics: Colforsin; Female; Heart Defects, Congenital; Hemodynamics; Humans; Infant, Newborn; Postoperative Complications; Treatment Outcome

2002
A post-receptor defect of adenylyl cyclase in severely failing myocardium from children with congenital heart disease.
    European journal of pharmacology, 1997, Jul-02, Volume: 330, Issue:1

    Topics: Adenosine Diphosphate; Adenylate Cyclase Toxin; Adenylyl Cyclases; Adolescent; Cell Membrane; Child; Child, Preschool; Colforsin; Female; GTP-Binding Proteins; Heart Atria; Heart Defects, Congenital; Heart Failure; Humans; Infant, Newborn; Male; Myocardium; Receptors, Adrenergic, beta; Virulence Factors, Bordetella

1997
Potentiating effects of forskolin on the cardiovascular teratogenicity of ephedrine in chick embryos.
    Toxicology letters, 1991, Volume: 56, Issue:1-2

    Topics: Abnormalities, Drug-Induced; Animals; Chick Embryo; Colforsin; Cyclic AMP; Dose-Response Relationship, Drug; Drug Synergism; Ephedrine; Heart Defects, Congenital; Teratogens

1991